Quantum-Si (NASDAQ:QSI) Receives Buy Rating from HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report issued on Wednesday,Benzinga reports. They presently have a $4.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 415.93% from the company’s previous close.

Separately, Canaccord Genuity Group reduced their price target on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday.

Quantum-Si Stock Down 22.4 %

Quantum-Si stock opened at $0.78 on Wednesday. The firm has a fifty day moving average of $0.86 and a 200-day moving average of $1.12. Quantum-Si has a 52-week low of $0.70 and a 52-week high of $2.43. The firm has a market capitalization of $110.37 million, a P/E ratio of -1.23 and a beta of 2.89.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.03. The firm had revenue of $0.79 million during the quarter, compared to the consensus estimate of $1.06 million. Quantum-Si had a negative return on equity of 33.02% and a negative net margin of 5,249.65%. On average, research analysts expect that Quantum-Si will post -0.71 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Public Employees Retirement System of Ohio acquired a new stake in Quantum-Si in the first quarter valued at $27,000. Bleakley Financial Group LLC bought a new stake in shares of Quantum-Si in the 1st quarter worth about $28,000. XTX Topco Ltd acquired a new stake in shares of Quantum-Si in the 2nd quarter valued at about $25,000. Virtu Financial LLC bought a new position in shares of Quantum-Si during the first quarter worth about $98,000. Finally, Price T Rowe Associates Inc. MD grew its stake in Quantum-Si by 11.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock worth $118,000 after purchasing an additional 5,945 shares in the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.